Venrock Adviser, LLC: 13F holdings
CIK 16159822026Q2
| Positions | 33 |
|---|
| Reported value | $3.3bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 33 (+0 vs prior quarter) |
|---|
| Reported value | $3.3bn (+23.1%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| APOGEE THERAPEUTICS INC | 8,493,321 | $1.1bn | 34.2% |
| ORKA ORUKA THERAPEUTICS INC | 4,148,428 | $394.8m | 12.0% |
| ERAS ERASCA INC | 17,891,812 | $327.8m | 9.9% |
| SYRE SPYRE THERAPEUTICS INC | 2,985,448 | $265.0m | 8.0% |
| DNTH DIANTHUS THERAPEUTICS INC | 1,180,000 | $115.0m | 3.5% |
| OCUL OCULAR THERAPEUTIX INC | 10,346,926 | $101.6m | 3.1% |
| DAMORA THERAPEUTICS INC | 3,603,595 | $93.7m | 2.8% |
| SVRA SAVARA INC | 14,745,943 | $90.8m | 2.8% |
| JBIO JADE BIOSCIENCES INC | 3,220,364 | $71.6m | 2.2% |
| COGT COGENT BIOSCIENCES INC | 1,642,166 | $63.6m | 1.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1615982")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples